Citi Downgrades Ultragenyx Pharma (RARE) to Sell

November 14, 2016 8:14 AM EST
Get Alerts RARE Hot Sheet
Price: $70.74 -1.7%

Rating Summary:
    16 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade RARE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Citi downgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral to Sell.

For an analyst ratings summary and ratings history on Ultragenyx Pharma click here. For more ratings news on Ultragenyx Pharma click here.

Shares of Ultragenyx Pharma closed at $82.06 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades, Hot Downgrades

Related Entities

Citi

Add Your Comment